Pulmonary Fibrosis
The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this more true than in the elucidation and verification of the pathogenetic basis upon which they develop. Scientific progress, most recently in the field of experimental therapy, has relied closely on interpreting data derived from animal modeling. Such models are used to identify the cellular interactions and molecular pathways involved in lung tissue repair and fibrosis. Over the coming years, the significance of new discoveries will continue to be evaluated using the in vivo analysis of animal models substituting for patients with actual pulmonary fibrosis. The commonest strategy to induce experimental pulmonary fibrosis is by directly administering a profibrotic agent to either wild-type animals or those that bear a specific genetic modification. The creation of new models has been greatly enhanced by the availability of stem cell lines and methods for introducing genetic mutations into these cells. Despite an increasing choice of models, there are still good reasons to continue adapting and using one of its earliest examples, the bleomycin model, in post-genomic pulmonary fibrosis research. A brief review of the exacting requirements of such research will place the strengths of this particular model in perspective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pulmonary fibrosis is also included in the host response to reverse the loss of essential metal after its sequestration by asbestos (Figure 3 and Figure 4) [64].”
From Asbestos and Iron (2023) · cites this paper as [64]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Self-citationLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Resolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Kaminski, N., Allard, J. D., Pittet, J. F., Zuo, F., Griffiths, M. J. D., Morris, D., Huang, X., Sheppard, D., & Heller, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1778 · Cited by 417
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Research works printed but not linked: 5
- 1993, Monogr Pathol, 36, 78
- 2002, Respir Res, 3, 1
- 1978, Am Rev Respir Dis, 117, 289
- 1996, Lab Invest, 74, 12
- 1993, Thorax, 48, 956
Cited by
Items 201–300 of 316
Jain, N., Bhushan, B. L. S., Natarajan, M., Mehta, R., Saini, D. K., & Chatterjee, K. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01499 · Cited by 13
Chen, K., Li, Q., Weng, C., Duan, Z., Zhang, D.-D., Chen, Z., Chen, J., & Wang, J. (2018) · Bioscience Reports · doi:10.1042/bsr20180445 · Cited by 13
Brown, R. H., Irvin, C. G., Allen, G. B., Shapiro, S. D., Martin, W. J., Kolb, M. R. J., Hyde, D., Nieman, G. F., CODY, D. D., Ishii, M., et al. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-116st · Cited by 13
Clinical potentials of human pluripotent stem cells in lung diseases
Quan, Y., & Wang, D. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-15 · Cited by 14
Santos‐Ribeiro, D., Lecocq, M., Beukelaer, M. D., Bouzin, C., Palmai‐Pallag, M., Yakoub, Y., Huaux, F., Horman, S., Perros, F., Pilette, C., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12177 · Cited by 13
Cryptogenic Organizing Pneumonia in Tomm5 –/– Mice
Vogel, P., Read, R. W., Rehg, J. E., & Hansen, G. M. (2012) · Veterinary Pathology · doi:10.1177/0300985812450723 · Cited by 13
Bronchopulmonary Dysplasia: New Developments in Treatment and Prevention
Pierro (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190917mp · Cited by 12
Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway
Yin, J.-Z., Li, Z.-Q., Zhang, X., Wan, Z.-J., Qin, H.-R., Yao, L.-H., Li, B.-L., 高福, & Yang, Y.-Y. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176293 · Cited by 11
Refine, reduce, replace: Imaging of fibrosis and arthritis in animal models
Marenzana, M., & Velde, G. V. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.02.001 · Cited by 11
Putri, K. S. S., Adhyatmika, A., Boorsma, C. E., Habibie, H., Ruigrok, M. J. R., Heukels, P., Timens, W., de Jager, M. H., Hinrichs, W. L. J., Olinga, P., et al. (2024) · Lung · doi:10.1007/s00408-024-00691-5 · Cited by 10
Qiao, B., Wu, Y., Li, X., Xu, Z., Duan, W., Hu, Y., Jia, W., Fan, Q., & Xing, H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8887017 · Cited by 10
Preventing Glutaminolysis: A Potential Therapy for Pulmonary Fibrosis
Esguerra, V. G., & Zhao, Y. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0119ed · Cited by 10
The histone demethylase KDM6B links obstructive sleep apnea to idiopathic pulmonary fibrosis
Han, S., Huang, J., Yang, C.-Q., Feng, J., & Wang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202402813r · Cited by 9
Yan, L., Wei, Y., Nan, H., Yin, Q., Qin, Y., Zhao, X. S., Chen, B., Zhao, G., Wei, J.-G., & Cui, G.-B. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.08.004 · Cited by 9
Chamorro-Herrero, I., & Zambrano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054413 · Cited by 9
Darniati, D., Setiyaningsih, S., Agungpriyono, D. R., & Handharyani, E. (2021) · Veterinary World · doi:10.14202/vetworld.2021.1007-1013 · Cited by 10
Effect of Lung Fibrosis on Glycogen Content in Different Extrapulmonary Tissues
Borges, E. L., Pinheiro, M. B., Prata, L. O., Sales, W. A., Silva, Y. A. J. B., Caliari, M. V., & Rodrigues‐Machado, M. D. G. (2013) · Lung · doi:10.1007/s00408-013-9539-4 · Cited by 9
Dabaghi, M., Singer, R., Noble, A., Tafoya, A. A., González-Martínez, D. A., Gupta, T., Formosa‐Dague, C., Rosas, I. O., Kolb, M. R. J., Shargall, Y., et al. (2025) · Biomaterials Science · doi:10.1039/d4bm00906a · Cited by 8
Hong, F., Li, J., Zhou, Y., & Wang, L. (2017) · Environmental Toxicology · doi:10.1002/tox.22493 · Cited by 8
RetractedCheng, L., Wang, D., Deng, B., Li, J., Zhang, J., Guo, X., Yan, T., Xin, Y., An, Y., Zhang, B., et al. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.001031 · Cited by 8
Paladini, R. D., Wei, G., Kundu, A., Zhao, Q., Bookbinder, L. H., Keller, G. A., Shepard, H. M., & Frost, G. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364729 · Cited by 8
A roadmap for developing and engineering in vitro pulmonary fibrosis models
Dabaghi, M., Carpio, M. B., Saraei, N., Moran-Mirabal, J. M., Kolb, M. R. J., & Hirota, J. A. (2023) · Biophysics Reviews · doi:10.1063/5.0134177 · Cited by 7
Wu, X., Chen, L., Cheng, Y., Zhang, Y., Yang, W., Pan, L., Fu, C., Zhu, H., & Zhang, M. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02747-3 · Cited by 7
Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin.
Demirkol, B., Gul, S. K., Çörtük, M., Fener, N., Yavuzsan, E., Eren, R., Baydili, K. N., Çekmen, M., & Çetınkaya, E. (2023) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v40i3.13847 · Cited by 9
CD5L Deficiency Protects Mice Against Bleomycin-Induced Pulmonary Fibrosis
Guo, Y., Zhu, M., & Shen, R. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2809209 · Cited by 7
Update on models of pulmonary fibrosis therapy for preclinical drug research
Antoniu, S. A., & Kolb, M. R. J. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903186100 · Cited by 10
Liu, X., Khadtare, N. S., Patel, H., Stephani, R. A., & Cantor, J. O. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.06.003 · Cited by 7
The levels of pro-fibrotic cytokines in pulmonary tuberculosis with minimal and extensive lesions
Nugrahenny, D., Astuti, T., Chozin, I., & Damayanti, N. (2018) · Lung India · doi:10.4103/lungindia.lungindia_396_17 · Cited by 7
Magro-López, E., Chamorro-Herrero, I., & Zambrano, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094921 · Cited by 7
Matrix Metalloproteinases and Their Inhibitors in Turnover and Degradation of Extracellular Matrix
Gill, S. E., & Parks, W. C. (2011) · Springer eBooks · doi:10.1007/978-3-642-16861-1_1 · Cited by 8
La investigación básica en neumología
Gea, J. (2008) · Archivos de Bronconeumología · doi:10.1157/13128329 · Cited by 7
Gea, J. (2008) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(08)60116-0 · Cited by 7
Mechanism of lungs fibrosis in mycobacterial infection
Kim, L. B., & Николаевна, П. А. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00187 · Cited by 6
Zuo, H., Zhou, W., Zhou, B., Zhang, Y., Xu, M., Huang, S., Alinejad, T., & Chen, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112645 · Cited by 6
Liebler–Tenorio, E., Lambertz, J., Ostermann, C., Sachse, K., & Reinhold, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082817 · Cited by 6
PULMONARY AND SYSTEMIC TOXICITY OF BLEOMYCIN ON SEVERE COMBINED IMMUNE DEFICIENCY MICE
Miyazawa, H., Takiguchi, Y., Hiroshima, K., Kurosu, K., Tada, Y., Kasahara, Y., Sakao, S., Tanabe, N., Tatsumi, K., & Kuriyama, T. (2008) · Experimental Lung Research · doi:10.1080/01902140701807621 · Cited by 6
Role of irbesartan in protection against pulmonary toxicity induced by bleomycin in rats
El-Gamal, M. A. (2013) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-034203847 · Cited by 6
The Diagnosis of Patellofemoral Derangements
Kummel, B. M. (1980) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)00287-6 · Cited by 7
Elshamy, A. M., Tantawy, A. F. E., Basha, E., Eltabaa, E. F., Arakeeb, H. M., Ahmed, A., Abdelsattar, A. M., Ibrahim, R. R., El‐Deeb, O. S., Eid, A. M., et al. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110284 · Cited by 6
Wang, Z., Liu, M., Ai, Y., Zheng, S., Chen, Y., Du, H., Yuan, S., Guo, X., Yuan, Y., Li, G., et al. (2023) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2023.102268 · Cited by 5
Experimental Models of Pulmonary Fibrosis and their Translational Potential
Adamčáková, J., Romana, P., & Mokrá, D. (2019) · Acta Medica Martiniana · doi:10.2478/acm-2019-0013 · Cited by 5
Shapiro, S. D. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200604-098aw · Cited by 5
Stem cell therapy for idiopathic pulmonary fibrosis: How far are we from the bench to the bedside?
Wang, Z., Zhang, X., Kang, Y., Zeng, Y., Liu, H., Chen, X., & Ma, L. (2013) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2013.68a2004 · Cited by 6
A Silica-Induced Pulmonary Fibrosis Model: Are We Closer to ‘Real Life’
Fireman, E. M. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000335237 · Cited by 5
Zhang, Y., Jia, X.-J., Xu, W., Ding, X.-Q., Wang, X.-M., Chi, X., Hu, Y., & Yang, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1410051 · Cited by 7
Molavinia, S., Goudarzi, M., Azemi, M. E., Basir, Z., Khorasgani, Z. N., Nooshabadi, M. R., Ebrahimi, R., & Khodayar, M. J. (2023) · PubMed Central · doi:10.22038/ajp.2023.22121 · Cited by 4
Strategies targeting fibrosis in pulmonary disease
Ask, K., Martin, G. E. M., Bonniaud, P., Kolb, M. R. J., & Gauldie, J. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.09.003 · Cited by 4
Self-citationPotential for phosphodiesterase inhibitors in the management of autoimmune diseases
Shenoy, P. D., Agarwal, V., Agarwal, A., Misra, R., & Naik, S. (2011) · Drug Development Research · doi:10.1002/ddr.20486 · Cited by 4
Wang, X., Zhou, T. J., Huang, S., Zhou, H., Ling, Y., Chen, T., Zhang, S., Wang, W., Wu, C., & Yin, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114536 · Cited by 3
Insight into the pathogenesis of interstitial lung diseases and near-to-native lung fibrosis models
Štefániková, M., Sedláková, V., Portakal, T., Hampl, A., Vaňhara, P., & Doubková, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-03504-4 · Cited by 3
Cheng, H., Gao, T., Sun, Y., Huang, F., Gu, X., Shan, C., Luo, S., & Wang, B. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00604.2024 · Cited by 3
Дыгай, А. М., Skurikhin, Е. G., Ermakova, N. N., Reztsova, A. M., Pershina, О. V., Khmelevskaya, E. S., Krupin, V. A., Stepanova, I. E., Reztsova, V. M., Artamonov, A. V., et al. (2013) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-013-2188-z · Cited by 4
Goto, T., Sano, A., Onishi, S., Hada, N., Kimata, R., Matsuo, S., Oyama, S., Kato, A., Mizuno, H., & Yamazaki, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-86544-4 · Cited by 2
A novel application for Cocoacrisp protein as a biomarker for experimental pulmonary fibrosis
Balharry, D. C., Sexton, K., Oreffo, V. I. C., & BéruBé, K. (2009) · Biomarkers · doi:10.1080/13547500903029736 · Cited by 2
ДО ПАТОГЕНЕЗУ ЕКСПЕРИМЕНТАЛЬНОГО ФІБРОЗУ ЛЕГЕНЬ У ТВАРИН (КЛІНІКО- ГЕМАТОЛОГІЧНІ ДОСЛІДЖЕННЯ)
Surtaieva, Y., & Мазуркевич, А. Й. (2022) · Вісник Полтавської державної аграрної академії · doi:10.31210/visnyk2022.03.19 · Cited by 3
Bleomicina: un modelo de fibrosis pulmonar
Benítez, S. (2006) · Revista del Instituto Nacional de Enfermedades Respiratorias · Cited by 6
Chemokines and Their Receptors in Fibrosis
Trujillo, G., & Hogaboam, C. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-020-1_14 · Cited by 2
Dietary Lutein Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
Chilakapati, S. R., Serasanambati, M., Manikonda, P. K., & Kanala, J. R. (2015) · International Journal of Phytomedicine · Cited by 2
EXTRACORPOREAL PHOTOPHERESIS IN A RAT MODEL OF PULMONARY FIBROSIS
Remund, K., Rechsteiner, T. J., Guo, Z., Höfer, M., & Boehler, A. (2009) · Experimental Lung Research · doi:10.1080/01902140902718205 · Cited by 2
Pandey, A. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i6.146 · Cited by 2
Yoshihara, M., Asatsuma, C., Masuko, A., Iwaasa, K., Saito, Y., Sone, H., & Kamiyama, S. (2023) · Biologics · doi:10.3390/biologics3030010 · Cited by 2
Kulshrestha, R., Rani, M., Dahiya, R., Singh, A., Doraiswamy, S., Bharadwaj, S., Batra, J., Kumar, P., Pandey, A., Dinda, A. K., et al. (2025) · Surgical and Experimental Pathology · doi:10.1186/s42047-025-00202-7 · Cited by 1
The Effect of Artesunate on Bleomycin‑Induced Pulmonary Fibrosis
Şengül, A., Okutan, O., Altınsoy, B., Anar, C. M., Yazıcı, O., Dede, F., Köktürk, S., Özer, C., Sönmez, O. F., & Metin, G. (2025) · Acta Clinica Croatica · doi:10.20471/acc.2025.64.01.03 · Cited by 1
Naghitorabi, M., Shayeganfar, H., Khodayar, M. J., Molavinia, S., Moosavi, M., Khorsandi, L., & Salehcheh, M. (2025) · Reports of Biochemistry and Molecular Biology · doi:10.61882/rbmb.14.1.29 · Cited by 1
Li, J., Lu, J., Zhang, Y., Ghazwani, M., Zhang, P., Gao, X., & Li, S. (2013) · Wiley eBooks · doi:10.1002/9781118610749.ch15 · Cited by 1
Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis
Chhina, M. K., Shlobin, O. A., Grant, G. M., & Nathan, S. D. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.4.419 · Cited by 1
Nath, R. K., Somasundaram, C., Xiong, W., Li, J. L., Bian, K., & Murad, F. (2010) · The Open Conference Proceedings Journal · doi:10.2174/22102892010010100141 · Cited by 1
Aziz, M., & Wang, P. (2014) · Springer eBooks · doi:10.1007/978-94-017-8765-9_9 · Cited by 1
Stem Cell Therapy for Neonatal Lung Diseases
Pierro, M., Ciarmoli, E., & Thébaud, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-28293-0_14 · Cited by 1
Magnetic Resonance Imaging in Animal Models of Respiratory Diseases
Beckmann, N., & Crémillieux, Y. (2016) · Medical radiology · doi:10.1007/174_2016_85 · Cited by 1
Assessment of fibrosis induced by Bleomycin in a rat model that resembles Oral Submucous Fibrosis
Khater, D. (2018) · Egyptian Dental Journal /Egyptian Dental Journal · doi:10.21608/edj.2018.78873 · Cited by 1
Ho, M., Ho, M. S. H., & Librach, C. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00015-3 · Cited by 1
Mutations in Surfactant Protein C and Interstitial Lung Disease
Panos, R. J., & Bridges, J. P. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-384-4_6 · Cited by 1
Tanneberger, A. E., Blomberg, R., Yendamuri, T., Noelle, H., Jacot, J. G., Burgess, J. K., & Magin, C. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.714004 · Cited by 1
Células NKT, macrófagos M2 e o desenvolvimento da fibrose pulmonar.
Grabarz, F. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2014.tde-20022015-171616 · Cited by 1
In vivo modeling systems for chronic obstructive pulmonary disease
Stevenson, C. S., & Underwood, D. C. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7760-1_2
TARGETED THERAPY FOR LIVER FIBROSIS AND CANCER
Zhang, Y. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Role of Progenitors in Pulmonary Fibrosis and Asthma
Banerjee, E. R. (2014) · Springer eBooks · doi:10.1007/978-81-322-2053-4_8
Regulation of liver X receptors by microRNA-155 in pulmonary fibrosis
Hasoo, M. K. (2013) · Enlighten: Theses (The University of Glasgow)
Lysophospholipid Regulation of Lung Fibrosis
Shea, B. S., & Tager, A. M. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch27
Matalon, S., & Adler, K. B. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-2002ed
Shapiro, S. D., Silverman, E. K., Westin, C., Gerard, C. J., Ingenito, E. P., & Reilly, J. J. (2006) · Journal of Organ Dysfunction · doi:10.1080/17471060600580631
Targeting fibrosis in respiratory lung disease
Froese, A., Farkas, L., Ask, K., Gauldie, J., & Kolb, M. R. J. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.06.001
Self-citationSynthesis and Characterization of Collagen-Mimicking Hydrogels to Examine Lung Fibrosis
Dummeldinger, M. (2014) · Library, Museums and Press - UDSpace (University of Delaware)
Brody, A. R., & Sullivan, D. E. (2006) · Informa Healthcare eBooks · doi:10.1201/9781420003147.ch12
Fibrogenèse pulmonaire induite par la toxicité de la bléomycine et son point de départ sous-pleural
Burgy, O. (2016) · theses.fr (ABES) · doi:10.70675/1a8954ecz5e2az462cza41dz21af6356beb5
BLEOMYCIN INDUCED –INTERSTITIAL PULMONARY FIBROSIS IN MICE
Abdelhafez, S. A., Abo-Shehata, M. E., Mostafa, F., Mostafa, A., & Essa, H. (2015) · Zagazig University Medical Journal · doi:10.21608/zumj.2015.4522
Identification of novel targets in fibrosis
Verneau, J. (2018) · UCL Discovery (University College London)
Tumor necrosis factor alpha and keratin 17 expression in oral submucous fibrosis in rat model
Latif, G. A. E. (2019) · Egyptian Dental Journal /Egyptian Dental Journal · doi:10.21608/edj.2015.71414
Role of Progenitors in Pulmonary Fibrosis and Asthma
Banerjee, E. R., & Henderson, W. R. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-16232-4_5
Respiratory Homeostatic Dysfunction, Lower Respiratory Tract Dysfunction
(2014) · CRC Press eBooks · doi:10.1201/b17276-4
Lung Organoids: A New Pathway into Lung Regeneration and Repair
Tian, L., Zhang, C. C., Rea-Moreno, M., & Chen, Y. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-93056-1_2
Modern Approaches to the Creation of 2D and 3D Cellular Models for the Study of Lung Fibrosis
Tolstoluzhinskaya, A., Basalova, N. A., & Efimenko, A. Y. (2024) · Cell and Tissue Biology · doi:10.1134/s1990519x26070023
Larson‐Casey, J. L., VU-TICAR, N. N., Craver, J., Migliaccio, C. T., Holian, A., Kendall, R. L., Albright, J. M., & Venosa, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00170-4
Hesse, C., Beneke, V., Konzok, S., Diefenbach, C., Sand, J. M. B., Rønnow, S. R., Karsdal, M. A., Jonigk, D., Sewald, K., Braun, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20438229
Wu, X., Chen, L., Cheng, Y., Zhang, Y., Yang, W., Pan, L., Fu, C., Zhu, H., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.24558118
Zheng, M., Liu, K., Li, L., Feng, C., & Wu, G. (2024) · Figshare · doi:10.6084/m9.figshare.24934429
Rønnow, S. R., Dabbagh, R. Q., Genovese, F., Nanthakumar, C. B., Barrett, V., Good, R. B., Brockbank, S., Cruwys, S., Jessen, H., Sørensen, G. L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12269618
Morozan, A. (2023) · eScholarship@McGill (McGill) · doi:10.82308/54309
Metadata
- Authors
- Chua, F., Gauldie, J., & Laurent, G. J.
- Affiliations
- The Royal Free Hospital (GB)
- ORCID
- Chua, Felix
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 33
- Issue
- 1
- Pages
- 9-13
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2051772841
- Cited by
- 305
- References
- 36
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 10 · 2023: 24 · 2022: 18 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary fibrosis, bleomycin-induced fibrosis, experimental fibrosis, genetic modification, stem cell lines, lung repair, fibrosis pathogenesis, postgenomics
- MeSH terms
- Animals, Antimetabolites, Antineoplastic, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Lung, Lung Diseases, Models, Biological, Mutation, Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.